- CA$211.38m
- CA$217.51m
- CA$65.51m
- 82
- 13
- 73
- 57
Annual income statement for Sylogist, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 15 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 37.6 | 38.1 | 38.7 | 69 | 65.5 |
| Cost of Revenue | |||||
| Gross Profit | 28.5 | 28.1 | 28 | 43.6 | 39.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 24.1 | 35.6 | 32.4 | 66.1 | 64 |
| Operating Profit | 13.5 | 2.47 | 6.28 | 2.95 | 1.54 |
| Net Income Before Taxes | 13.5 | 2.47 | 6.28 | 2.95 | 1.54 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 10 | 1.92 | 4.37 | 2.54 | 1.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 10 | 1.92 | 4.37 | 2.54 | 1.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 10 | 1.92 | 4.37 | 2.54 | 1.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.446 | 0.104 | 0.213 | 0.128 | 0.047 |
| Dividends per Share |